Transdiagnostic comparison of visual working memory capacity in bipolar disorder and schizophrenia.

Attention Bipolar disorder Cognitive dysfunction Schizophrenia Working memory capacity

Journal

International journal of bipolar disorders
ISSN: 2194-7511
Titre abrégé: Int J Bipolar Disord
Pays: Germany
ID NLM: 101622983

Informations de publication

Date de publication:
02 Apr 2021
Historique:
received: 05 03 2020
accepted: 22 12 2020
entrez: 2 4 2021
pubmed: 3 4 2021
medline: 3 4 2021
Statut: epublish

Résumé

Impaired working memory is a core cognitive deficit in both bipolar disorder and schizophrenia. Its study might yield crucial insights into the underpinnings of both disorders on the cognitive and neurophysiological level. Visual working memory capacity is a particularly promising construct for such translational studies. However, it has not yet been investigated across the full spectrum of both disorders. The aim of our study was to compare the degree of reductions of visual working memory capacity in patients with bipolar disorder (PBD) and patients with schizophrenia (PSZ) using a paradigm well established in cognitive neuroscience. 62 PBD, 64 PSZ, and 70 healthy controls (HC) completed a canonical visual change detection task. Participants had to encode the color of four circles and indicate after a short delay whether the color of one of the circles had changed or not. We estimated working memory capacity using Pashler's K. Working memory capacity was significantly reduced in both PBD and PSZ compared to HC. We observed a small effect size (r = .202) for the difference between HC and PBD and a medium effect size (r = .370) for the difference between HC and PSZ. Working memory capacity in PSZ was also significantly reduced compared to PBD with a small effect size (r = .201). Thus, PBD showed an intermediate level of impairment. These findings provide evidence for a gradient of reduced working memory capacity in bipolar disorder and schizophrenia, with PSZ showing the strongest degree of impairment. This underscores the importance of disturbed information processing for both bipolar disorder and schizophrenia. Our results are compatible with the cognitive manifestation of a neurodevelopmental gradient affecting bipolar disorder to a lesser degree than schizophrenia. They also highlight the relevance of visual working memory capacity for the development of both behavior- and brain-based transdiagnostic biomarkers.

Sections du résumé

BACKGROUND BACKGROUND
Impaired working memory is a core cognitive deficit in both bipolar disorder and schizophrenia. Its study might yield crucial insights into the underpinnings of both disorders on the cognitive and neurophysiological level. Visual working memory capacity is a particularly promising construct for such translational studies. However, it has not yet been investigated across the full spectrum of both disorders. The aim of our study was to compare the degree of reductions of visual working memory capacity in patients with bipolar disorder (PBD) and patients with schizophrenia (PSZ) using a paradigm well established in cognitive neuroscience.
METHODS METHODS
62 PBD, 64 PSZ, and 70 healthy controls (HC) completed a canonical visual change detection task. Participants had to encode the color of four circles and indicate after a short delay whether the color of one of the circles had changed or not. We estimated working memory capacity using Pashler's K.
RESULTS RESULTS
Working memory capacity was significantly reduced in both PBD and PSZ compared to HC. We observed a small effect size (r = .202) for the difference between HC and PBD and a medium effect size (r = .370) for the difference between HC and PSZ. Working memory capacity in PSZ was also significantly reduced compared to PBD with a small effect size (r = .201). Thus, PBD showed an intermediate level of impairment.
CONCLUSIONS CONCLUSIONS
These findings provide evidence for a gradient of reduced working memory capacity in bipolar disorder and schizophrenia, with PSZ showing the strongest degree of impairment. This underscores the importance of disturbed information processing for both bipolar disorder and schizophrenia. Our results are compatible with the cognitive manifestation of a neurodevelopmental gradient affecting bipolar disorder to a lesser degree than schizophrenia. They also highlight the relevance of visual working memory capacity for the development of both behavior- and brain-based transdiagnostic biomarkers.

Identifiants

pubmed: 33797645
doi: 10.1186/s40345-020-00217-x
pii: 10.1186/s40345-020-00217-x
pmc: PMC8018920
doi:

Types de publication

Journal Article

Langues

eng

Pagination

12

Références

Clin Neurosci. 1995;3(2):89-97
pubmed: 7583624
JAMA Psychiatry. 2013 Oct;70(10):1107-12
pubmed: 23925787
Psychon Bull Rev. 2010 Apr;17(2):243-9
pubmed: 20382927
Hum Brain Mapp. 2009 Dec;30(12):3958-69
pubmed: 19449330
Neurosci Biobehav Rev. 2010 May;34(6):897-921
pubmed: 19954751
Trends Cogn Sci. 2013 Aug;17(8):391-400
pubmed: 23850263
Sci Rep. 2019 Feb 4;9(1):1155
pubmed: 30718809
Educ Psychol Rev. 2014 Jun 1;26(2):197-223
pubmed: 25346585
Am J Psychiatry. 2010 Jun;167(6):686-93
pubmed: 20360319
Psychon Bull Rev. 2010 Oct;17(5):673-9
pubmed: 21037165
Bipolar Disord. 2004 Dec;6(6):540-9
pubmed: 15541070
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Cereb Cortex. 2013 Jul;23(7):1582-92
pubmed: 22661407
Behav Res Methods. 2019 Jun;51(3):1360-1370
pubmed: 30076533
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
Bipolar Disord. 2007 Aug;9(5):478-89
pubmed: 17680918
Science. 1992 Jan 31;255(5044):556-9
pubmed: 1736359
Front Psychiatry. 2013 Aug 08;4:87
pubmed: 23964248
Science. 2008 Aug 8;321(5890):851-4
pubmed: 18687968
Mol Psychiatry. 2019 Nov 19;:
pubmed: 31740754
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Psychiatry Res. 2010 Apr 30;182(1):22-9
pubmed: 20227857
Biol Psychiatry. 2007 Jul 15;62(2):179-86
pubmed: 17161829
World Psychiatry. 2014 Feb;13(1):28-35
pubmed: 24497240
Psychon Bull Rev. 2011 Apr;18(2):324-30
pubmed: 21331668
J Neurosci. 2009 Jul 29;29(30):9481-9
pubmed: 19641111
Arch Gen Psychiatry. 2010 Jun;67(6):570-7
pubmed: 20530006
Psychol Rev. 1956 Mar;63(2):81-97
pubmed: 13310704
Schizophr Bull. 2019 Sep 11;45(5):1001-1011
pubmed: 31206163
Trends Cogn Sci. 2006 Apr;10(4):139-41
pubmed: 16497538
Psychon Bull Rev. 2002 Dec;9(4):637-71
pubmed: 12613671
Schizophr Bull. 2019 Jun 18;45(4):804-812
pubmed: 30260448
Mol Psychiatry. 2019 Sep;24(9):1296-1318
pubmed: 30279458
Acta Psychiatr Scand. 2011 Mar;123(3):165-74
pubmed: 21092023
J Abnorm Psychol. 2005 Nov;114(4):599-611
pubmed: 16351383
Schizophr Res. 2003 Feb 1;59(2-3):99-113
pubmed: 12414067
Schizophr Res. 1999 Sep 29;39(2):127-32; discussion 161-2
pubmed: 10507523
Psychol Med. 2011 Feb;41(2):225-41
pubmed: 20836900
J Abnorm Psychol. 2017 Nov;126(8):1077-1086
pubmed: 29154568
J Exp Psychol Learn Mem Cogn. 2018 Apr;44(4):588-603
pubmed: 28933904
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Cogn Psychol. 2014 Jun;71:1-26
pubmed: 24531497
World Psychiatry. 2017 Oct;16(3):227-235
pubmed: 28941101
Percept Psychophys. 1988 Oct;44(4):369-78
pubmed: 3226885
Nature. 1997 Nov 20;390(6657):279-81
pubmed: 9384378
Eur Neuropsychopharmacol. 2015 Feb;25(2):192-202
pubmed: 25156468
Biol Psychiatry. 2011 Dec 15;70(12):1159-68
pubmed: 21861986
Arch Gen Psychiatry. 2007 Nov;64(11):1229-40
pubmed: 17984392
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Am J Psychiatry. 2004 Feb;161(2):262-70
pubmed: 14754775
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
J Abnorm Psychol. 2012 Aug;121(3):784-794
pubmed: 22708888
Bipolar Disord. 2018 May;20(3):184-194
pubmed: 29345040
Front Psychiatry. 2018 May 29;9:202
pubmed: 29896123
Neuropsychiatr Dis Treat. 2015 Dec 17;11:3111-25
pubmed: 26719696
Nature. 2004 Apr 15;428(6984):751-4
pubmed: 15085133
Schizophr Bull. 2013 Jan;39(1):168-78
pubmed: 21914644
World Psychiatry. 2014 Oct;13(3):224-32
pubmed: 25273286
Behav Brain Sci. 2001 Feb;24(1):87-114; discussion 114-85
pubmed: 11515286
Biol Psychiatry. 2008 Jul 1;64(1):34-9
pubmed: 18374901
Am J Psychiatry. 2016 Apr 1;173(4):373-84
pubmed: 26651391
Eur Neuropsychopharmacol. 2015 Feb;25(2):158-68
pubmed: 25261263
Schizophr Bull. 2014 May;40(3):516-22
pubmed: 24574307
Am J Psychiatry. 2013 Nov;170(11):1275-84
pubmed: 23771174
Schizophr Res. 2011 Nov;132(2-3):220-7
pubmed: 21764562
Psychol Med. 2019 Sep;49(12):1971-1979
pubmed: 31284882
Bipolar Disord. 2006 Apr;8(2):117-23
pubmed: 16542181
J Affect Disord. 2016 Nov 15;205:378-386
pubmed: 27573491
J Affect Disord. 2018 Mar 15;229:125-134
pubmed: 29306692
J Clin Psychiatry. 2004 Nov;65(11):1483-90
pubmed: 15554760
Schizophr Bull. 2012 Jan;38(1):43-52
pubmed: 22080498
Schizophr Res. 2006 Feb 15;82(1):65-74
pubmed: 16377155
Biol Psychiatry. 2008 Jul 1;64(1):11-7
pubmed: 18400207
Behav Res Methods. 2018 Apr;50(2):576-588
pubmed: 28389852
Neuropsychologia. 1971 Mar;9(1):97-113
pubmed: 5146491
Bipolar Disord. 2007 Jun;9 Suppl 1:136-44
pubmed: 17543032
Arch Gen Psychiatry. 2006 Nov;63(11):1189-97
pubmed: 17088499
Annu Rev Clin Psychol. 2015;11:251-81
pubmed: 25581236
Nature. 2004 Apr 15;428(6984):748-51
pubmed: 15085132
PLoS One. 2012;7(11):e48586
pubmed: 23152783
Cogn Psychol. 2005 Aug;51(1):42-100
pubmed: 16039935
J Exp Psychol Gen. 2002 Mar;131(1):48-64
pubmed: 11900102
Schizophr Bull. 2015 Sep;41(5):1095-104
pubmed: 25616505
Am J Psychiatry. 2014 Apr;171(4):395-7
pubmed: 24687194
Cereb Cortex. 2015 Sep;25(9):2494-506
pubmed: 24675869
Arch Gen Psychiatry. 2002 Feb;59(2):146-53
pubmed: 11825136
Neuroimage. 2003 Nov;20(3):1518-30
pubmed: 14642464
Schizophr Res. 2007 May;92(1-3):160-7
pubmed: 17376656
Neuropsychology. 2013 Mar;27(2):220-9
pubmed: 23527650
J Neurosci. 2018 Sep 26;38(39):8378-8387
pubmed: 30104335
Schizophr Res. 2007 Mar;91(1-3):159-68
pubmed: 17291722
Schizophr Res. 2008 Mar;100(1-3):144-52
pubmed: 17804202
Br J Psychiatry. 1992 Jul;161:69-74
pubmed: 1638332
J Affect Disord. 2000 Jan-Mar;57(1-3):95-8
pubmed: 10708820
Nature. 2005 Nov 24;438(7067):500-3
pubmed: 16306992
J Affect Disord. 2012 Feb;136(3):328-39
pubmed: 22169253
Neuropsychology. 2009 Jan;23(1):71-80
pubmed: 19210034
Biol Psychiatry. 2010 Oct 1;68(7):603-9
pubmed: 20570242
Prog Neurobiol. 2011 Dec;95(4):686-702
pubmed: 21664943
Nat Neurosci. 2008 Jan;11(1):103-7
pubmed: 18066057
Schizophr Bull. 2019 Sep 11;45(5):991-1000
pubmed: 31317191

Auteurs

Catherine V Barnes-Scheufler (CV)

Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Goethe University, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany.

Caroline Passow (C)

Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Goethe University, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany.

Lara Rösler (L)

Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Goethe University, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany.
Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.

Jutta S Mayer (JS)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.

Viola Oertel (V)

Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Goethe University, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany.

Sarah Kittel-Schneider (S)

Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Goethe University, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany.
Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Würzburg, Würzburg, Germany.

Silke Matura (S)

Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Goethe University, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany.

Andreas Reif (A)

Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Goethe University, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany.

Robert A Bittner (RA)

Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Goethe University, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany. robert.bittner@med.uni-frankfurt.de.
Ernst Strüngmann Institute for Neuroscience (ESI) in Cooperation with Max Planck Society, Frankfurt am Main, Germany. robert.bittner@med.uni-frankfurt.de.

Classifications MeSH